605 results on '"Wang, Cheng-Ping"'
Search Results
2. Prognostic significance of adjuvant therapy and specific radiation dosages in Taiwanese patients with oral cavity cancer and extra-nodal extension: a nationwide cohort study
3. The branched N-glycan of PD-L1 predicts immunotherapy responses in patients with recurrent/metastatic HNSCC
4. ASO Visual Abstract: Feasibility of Using Needle Rinse Fluid for Cobas HPV Assay in Diagnosing HPV+ Oropharyngeal Cancer with Neck Lymph Node Aspiration
5. Margin-to-depth ratio as an independent prognostic factor in resected oral cavity squamous cell carcinoma: A nationwide cohort study
6. Proactive Swallowing Rehabilitation in Patients with Recurrent Oral Cancer Receiving Salvage Treatment: Long-Term Swallowing-Related Outcomes
7. Margin to depth of invasion ratio as an indicator for stratifying close margins in early-stage oral squamous cell carcinoma
8. Is the N2A Category Still Necessary for Oral Cancer Patients After Extranodal Extension Upgrade?
9. Indications for elective neck dissection in cT1N0M0 oral cavity cancer according to the AJCC eight edition: A nationwide study
10. Rising incidence of HPV positive oropharyngeal cancer in Taiwan between 1999 and 2014 where betel nut chewing is common
11. Diagnostic performance of core needle biopsy for nodal recurrences in patients with head and neck squamous cell carcinoma
12. Kinetics of EBV antibody‐based NPC risk scores in Taiwan NPC multiplex families.
13. Association Between Antibodies That Bind Epstein-Barr Virus (EBV) gp350 and gH/gL and Shedding of EBV in Saliva From Nasopharyngeal Carcinoma Multiplex Family Members in Taiwan.
14. Impact of invasion into cervical esophagus for patients with hypopharyngeal squamous cell carcinoma
15. ASO Visual Abstract: Is the N2A Category Still Necessary for Oral Cancer Patients After Extranodal Extension Upgrade?
16. Clinical Outcomes of Taiwanese Patients with Resected Oral Cavity Squamous Cell Carcinoma Who Underwent Reconstruction with Free Versus Local Flaps
17. Comparing the clinical outcomes of initial surgery and primary definitive radiotherapy with a dosage of 6600 cGy or higher in cT1−2N0M0 oral cavity squamous cell carcinoma: A nationwide cohort study
18. Cleaning and harmonizing medical image data for reliable AI: Lessons learned from longitudinal oral cancer natural history study data
19. Long-term swallowing-related outcomes in oral cancer patients receiving proactive swallowing therapy
20. Physical activity and fitness in survivors of head and neck cancer
21. Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis
22. Wheel wear comparison between motor car and trailer of intercity train
23. The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer
24. Prognostic impact of bridge or neoadjuvant induction chemotherapy in patients with resected oral cavity cancer: A nationwide cohort study.
25. Prognostic impact of elective tracheotomy in resected oral cavity squamous cell carcinoma: A nationwide cohort study.
26. Is elective neck dissection justified in cT2N0M0 oral cavity cancer defined according to the AJCC eighth edition staging system?
27. Pilot imaging study of o-BMVC foci for discrimination of indeterminate cytology in diagnosing fine-needle aspiration of thyroid nodules
28. Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma
29. Malignant transformation to oral cancer by subtype of oral potentially malignant disorder: A prospective cohort study of Taiwanese nationwide oral cancer screening program
30. Evaluation of Oral Cytology Brushings Correlated with Histopathology with High Sensitivity for Carcinoma
31. Patterns of Interindividual Variability in the Antibody Repertoire Targeting Proteins Across the Epstein-Barr Virus Proteome
32. Artificial intelligence-based cancer progression prediction of oral premalignant lesions via self-supervised deep learning on histopathology.
33. Cleaning and harmonizing medical image data for reliable AI: Lessons learned from longitudinal oral cancer natural history study data
34. Comparative clinical outcomes of Taiwanese patients with resected buccal and tongue squamous cell carcinomas
35. Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma
36. Clinical characteristics and treatment outcome of oropharyngeal squamous cell carcinoma in an endemic betel quid region
37. Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review
38. Validation of the Supportive Care Needs Survey Screening Tool Chinese Version for Patients With Head and Neck Cancer in Taiwan
39. Data from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies
40. Supplementary Table S2 from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies
41. Supplementary Methods S1 from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies
42. Data from Revisit of Field Cancerization in Squamous Cell Carcinoma of Upper Aerodigestive Tract: Better Risk Assessment with Epigenetic Markers
43. Supplementary Tables 1-2, Figures 1-11 from Revisit of Field Cancerization in Squamous Cell Carcinoma of Upper Aerodigestive Tract: Better Risk Assessment with Epigenetic Markers
44. Supplementary Figure 2 from Epstein–Barr Virus Serology as a Potential Screening Marker for Nasopharyngeal Carcinoma among High-Risk Individuals from Multiplex Families in Taiwan
45. Figure S3 from Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan
46. Tables S2-S4 from Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan
47. Supplemental Figure 5 from High Levels of Antibody that Neutralize B-cell Infection of Epstein–Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma
48. Supplemental Figure 2 from High Levels of Antibody that Neutralize B-cell Infection of Epstein–Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma
49. Supplementary Tables S1-S2 from Prognostic Utility of Anti-EBV Antibody Testing for Defining NPC Risk among Individuals from High-Risk NPC Families
50. Supplemental Figure 4 from High Levels of Antibody that Neutralize B-cell Infection of Epstein–Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.